Published in Br J Anaesth on July 01, 2000
Severe neurologic manifestations in acute intermittent porphyria developed after spine surgery under general anesthesia: a case report. Korean J Anesthesiol (2014) 0.80
Anaesthesia is also risky in patients with porphyria. BMJ (2000) 0.75
Anesthetic implication of tricuspid valve replacement in a patient with acute intermittent porphyria. Ann Card Anaesth (2016) 0.75
A case report of anesthesia management in the liver transplantation recipient with porphyria -A case report-. Korean J Anesthesiol (2012) 0.75
Anesthesia for hemicolectomy in a known porphyric with cecal malignancy. Saudi J Anaesth (2015) 0.75
Congenital erythropoietic porphyria: anesthetic implications. J Anesth (2009) 0.75
Anaesthesia for the porphyric patient. Anaesthesia (1993) 3.12
The acute porphyrias. Lancet (1997) 1.80
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet (1996) 1.78
The prevention of hepatitis. S Afr Med J (1994) 1.67
Early effects of total hepatectomy on haemodynamic state and organ uptake of catecholamines in the pig. Br J Anaesth (1996) 1.40
Liver disease in erythropoietic protoporphyria: insights and implications for management. Gut (2007) 1.31
A structured assessment of newly qualified medical graduates. Med Educ (2005) 1.28
Clinical use of magnesium infusions in anesthesia. Anesth Analg (1992) 1.13
Molecular characterization of erythropoietic protoporphyria in South Africa. Br J Dermatol (2008) 0.92
Homozygous variegate porphyria in South Africa: genotypic analysis in two cases. Mol Genet Metab (2000) 0.86
Variegate porphyria. Semin Liver Dis (1998) 0.84
Liver disease in erythropoietic protoporphyria: insights and implications for management. Postgrad Med J (2007) 0.82
Treatment of acute porphyria. Hosp Med (2001) 0.82
Effect of magnesium on coagulation as measured by thrombelastography. Br J Anaesth (1995) 0.82
Identification of the first variegate porphyria mutation in an indigenous black South African and further evidence for heterogeneity in variegate porphyria. Mol Genet Metab (2001) 0.81
Propofol as an i.v. anaesthetic induction agent in variegate porphyria. Br J Anaesth (1991) 0.80
Inhibition of mammalian protoporphyrinogen oxidase by acifluorfen. Biochem Mol Biol Int (1994) 0.79
Drugs in the acute porphyrias--toxicogenetic diseases. Cell Mol Biol (Noisy-le-grand) (1997) 0.78
Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study. S Afr Med J (1992) 0.77
Detection of four mutations in six unrelated South African patients with acute intermittent porphyria. Mol Cell Probes (1996) 0.77
Identification and characterisation of a deletion (537delAT) in the protoporphyrinogen oxidase gene in a South African variegate porphyria family. Hum Mutat (1998) 0.77
Acute intermittent porphyria: the in vitro expression of mutant hydroxymethylbilane synthase. Mol Cell Probes (1997) 0.76
A jaundiced look at the management of hepatitis? S Afr Med J (1997) 0.75
Primary biliary cirrhosis. A retrospective survey at Groote Schuur Hospital, Cape Town. S Afr Med J (1990) 0.75
Prophylaxis and treatment of malaria in people with the acute porphyrias. S Afr Med J (1988) 0.75
Mapping of the variegate porphyria (VP) gene: contradictory evidence for linkage between VP and microsatellite markers at chromosome 14q32. Hum Genet (1996) 0.75
Acute intermittent porphyria--an underdiagnosed cause of abdominal pain. S Afr Med J (1989) 0.75
Primary pyogenic psoas abscess. A case report. S Afr J Surg (1986) 0.75
Identification of two novel mutations in the hydroxymethylbilane synthase gene in three patients from two unrelated families with acute intermittent porphyria. Hum Hered (1998) 0.75
Acute liver failure. S Afr Med J (1992) 0.75